Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

148 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Guselkumab for the treatment of moderate-to-severe plaque psoriasis in pediatric patients: results of the phase 3, randomized, placebo-controlled PROTOSTAR study.
Prajapati VH, Seyger MMB, Wilsmann-Theis D, Szakos E, Kaszuba A, van Hartingsveldt B, Jett M, Jiang G, Li S, Sinha V, Crauwels H, DeKlotz CMC, Paller AS. Prajapati VH, et al. Among authors: seyger mmb. Br J Dermatol. 2024 Dec 21:ljae502. doi: 10.1093/bjd/ljae502. Online ahead of print. Br J Dermatol. 2024. PMID: 39708367
Exploring shared clinical features and successful therapeutic interventions in CARD14-associated papulosquamous eruption.
Rossel SVJ, Reich A, Baniel A, Wertheim-Tysarowska K, Frommherz LH, Nolberczak D, Lesiak A, Kwiek B, Osipowicz K, Bekkenk MW, Spruijt L, Seyger MMB, Kołt-Kamińska M, Giehl K, Nartbutt J, Vreeburg M, Steijlen PM, Sprecher E, van Geel M, Gostyński AH. Rossel SVJ, et al. Among authors: seyger mmb. J Eur Acad Dermatol Venereol. 2024 Nov 20. doi: 10.1111/jdv.20420. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 39564931 No abstract available.
Longer-term safety and efficacy of baricitinib for atopic dermatitis in pediatric patients 2 to <18 years old: a randomized clinical trial of extended treatment to 3.6 years.
Wollenberg A, Ikeda M, Chu CY, Eichenfield LF, Seyger MMB, Prakash A, Angle R, Zhu D, Pontes M, Paller AS. Wollenberg A, et al. Among authors: seyger mmb. J Dermatolog Treat. 2024 Dec;35(1):2411834. doi: 10.1080/09546634.2024.2411834. Epub 2024 Nov 10. J Dermatolog Treat. 2024. PMID: 39522957 Free article. Clinical Trial.
Drug Survival of Dupilumab, Methotrexate, and Cyclosporine A in Children With Atopic Dermatitis.
van der Rijst LP, Kamphuis E, Schuttelaar MLA, Hurmuz R, Seyger MMB, Caron AGM, Zuithoff NPA, Nguyen NT, Kamsteeg M, de Bruin-Weller MS, Pasmans SGMA, Middelkamp-Hup MA, de Graaf M. van der Rijst LP, et al. Among authors: seyger mmb. JAMA Dermatol. 2024 Oct 16:e243717. doi: 10.1001/jamadermatol.2024.3717. Online ahead of print. JAMA Dermatol. 2024. PMID: 39412782
Switching to Interleukin-23 Inhibitors After Ineffectiveness of Ustekinumab: Evaluating Real-World Outcomes in Psoriasis Treatment.
Thomas SE, Seyger MMB, Mangnus JE, Otero ME, Gostynski AH, Njoo MD, Ossenkoppele PM, Haeck IM, Hendricksen-Roelofzen JHJ, Körver JEM, Dodemont SRP, Tupker RA, Berends MAM, Weppner-Parren LMJT, Keijsers RRMC, Oostveen AM, Peters B, Mommers R, van Doorn MBA, Tjioe M, Veldkamp WR, Kuijpers ALA, Kleinpenning MM, de Jong EMGJ, van den Reek JMPA. Thomas SE, et al. Among authors: seyger mmb. Am J Clin Dermatol. 2024 Jul;25(4):685-688. doi: 10.1007/s40257-024-00868-x. Epub 2024 May 27. Am J Clin Dermatol. 2024. PMID: 38802618 No abstract available.
The lifestyle of psoriasis patients and their motivation to change.
Al-Gawahiri M, van den Reek JMPA, van Acht MR, Evers AWM, de Jong EMGJ, Seyger MMB. Al-Gawahiri M, et al. Among authors: seyger mmb. J Eur Acad Dermatol Venereol. 2024 Oct;38(10):e836-e841. doi: 10.1111/jdv.19923. Epub 2024 Feb 24. J Eur Acad Dermatol Venereol. 2024. PMID: 38400656 No abstract available.
148 results